![](\"\/en\/wp-content\/uploads\/EDITOR\/e86d35de-fc51-44ff-817a-24a767784081.jpg#257\")
A group of physicians and developers examine Lunit INSIGHT CXR, installed at Salud Digna Healthcare Network, located in Mexico.<\/p>\n<\/figcaption>
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
Up-to-date AI technology for chest and breast radiology<\/h3>\n
<\/p>\n
<\/p>\n
During RSNA 2019, Lunit will be presenting the latest version of its AI solution for chest x-ray, Lunit INSIGHT CXR\u2014which had gained CE mark recently\u2014and for mammography, Lunit INSIGHT MMG. The software has been first introduced in RSNA 2017 and 2018 respectively.<\/p>\n
<\/p>\n
According to Lunit, the chest x-ray software product has been highlighted recently in major publications such asRadiology<\/em>,Scientific Reports<\/em>, andJAMA Open Network<\/em>. The publications validate the performance of the chest radiography algorithm (Lunit INSIGHT CXR) as well as its clinical value in an emergency department and TB screening setting.<\/p>\n <\/p>\n The algorithm for breast cancer detection, Lunit INSIGHT MMG, has also displayed top-level performance in the detection of breast cancer, upon multiple reader studies. \u201cThe studies show that when the readers use our software, it lead to an increase in breast cancer detection by 24%,\u201d said Hyo-Eun Kim, PhD, Head of Breast Radiology at Lunit. \u201cThis shows that our product can provide tangible benefits to both physicians and patients, detecting more breast cancer and reducing invasive, unnecessary biopsies.\u201d<\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n Merely 1-2 years since its launching, Lunit AI software system has gone through major improvements\u2014not only in its algorithmic performance but also in user compatibilities such as user interface and report generation, to facilitate better workflow.<\/p>\n <\/p>\n <\/p>\n \u201cWe have conducted on-site interviews with our customers all throughout the year,\u201d said Minhong Jang, Chief Business Officer of Lunit. \u201cWe listen to what they have to say, both the positive and the negative comments, and align with their needs to make the product useful and helpful for the radiologists in the field.\u201d<\/p>\n <\/p>\n <\/p>\n Since the beginning of the year until recently, the company saw an increase in the number of images analyzed with commercially installed Lunit INSIGHT in a clinical setting. With installations in multiple global sites, Lunit INSIGHT products are quickly expanding its presence in the international market.<\/p>\n <\/p>\n <\/p>\n \u201cIt is true that the software showed some false positives upon its initial installation earlier this year,\u201d said a radiologist who uses Lunit INSIGHT CXR for daily clinical interpretations. \u201cHowever, with subsequent update in the software, I noticed a significant decrease in the appearance of false positives. It has been a much satisfying improvement. Now, with AI, I feel like I have a double-checking, safety net system.\u201d<\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n \u201cWe\u2019ve been through extensive developments in the past year, which includes partnerships with major players in the industry,\u201d said Brandon Suh, MD, CEO of Lunit. \u201cWe have a strong ongoing partnership with FUJIFILM and others like NVIDIA, EnvoyAI, and INFINITT, and also added new partnerships with Microsoft and more. We look forward to reaching further milestones with these partners and together create meaningful and impactful changes in digital health.\u201d<\/p>\n <\/p>\n <\/p>\n One of the most mature products\u2014Lunit INSIGHT CXR\u2014has recently received a CE mark, now ready for sales in the European market. The mammography solution, Lunit INSIGHT MMG is expected to get CE certification by the end of this year. FDA clearance is expected by 2020. These products will be available for demonstration during RSNA, not only at Lunit booth, but also displayed at following booths: FUJIFILM REiLi station, GE Healthcare, EnvoyAI, and INFINITT.<\/p>\n <\/p>\n <\/p>\n At RSNA this year, Lunit's researchers will be presenting seven abstracts, and Suh will be on stage at the AI Theater to present Lunit's recent achievements and future developments.<\/p>\n <\/p>\n <\/p>\n Since its first attendance at RSNA back in 2016, this is Lunit\u2019s fourth year as an exhibitor. In 2016, the objective was to let the attendees know of its groundbreaking AI technology and research. In 2017, the company showcased its first software product, Lunit INSIGHT CXR, and Lunit INSIGHT MMG the following year.<\/p>\n \u201cWe\u2019re growing with years of attendance in RSNA,\u201d said Suh. \u201cEvery year, we see the AI pavilion enlarged in scale and importance. We are happy to see that the acceptance of advanced technology within the medical society is being amplified. We look forward to meeting more people at RSNA this year.\u201d<\/p>\n <\/p>\n <\/p>\nQuickly evolving to meet the field\u2019s needs\u2014Lunit INSIGHT \u201ca safety net\u201d<\/h3>\n
More partnership with global players\u2014a fourth-time exhibitor at RSNA<\/h3>\n